Description
Clinical trial protocol writing for Singapore-based sponsors
The protocol is the reference document for the ethics review board, the Health Sciences Authority (HSA) and the study team throughout a trial. This service develops full protocols for pharmaceutical and biotech companies running studies in Singapore, written by medical writing specialists who work to ICH-GCP, and includes the statistical analysis plan, ethics documentation and informed consent forms.
What you receive
- Full protocol development following ICH E6 and the SPIRIT structure
- Objectives, endpoints, eligibility criteria and schedule of assessments
- A statistical analysis plan, including sample size justification and analysis populations
- Documentation for IRB or ethics committee submission, such as the DSRB or institutional review boards
- Informed consent form drafting in plain English
- A protocol synopsis for registration and presentations
How it works
- A kick-off meeting to review the product, available data and submission timeline
- A synopsis and outline are agreed with your clinical and regulatory teams
- The full protocol, SAP and consent documents are drafted and reviewed in rounds
- Final documents are prepared for ethics and HSA submission
Standards we follow
Documents follow ICH E6 (GCP), ICH E9 and SPIRIT, HSA clinical trial requirements and, where applicable, the Human Biomedical Research Act, together with GPP3, COPE and ICMJE.
Turnaround and price
US$17,036 (approximately S$21,800; exchange rates may vary). The timeline is confirmed at kick-off based on trial phase, complexity and your submission date.
Frequently asked questions
Is the informed consent form included?
Yes. Informed consent form drafting is part of this service, alongside the protocol and statistical analysis plan.
What do you need before starting?
Product information, prior study results or the Investigator's Brochure, and your team's initial design concept.
Questions before ordering? Contact our team or request a quote.


